The FDA announced on Feb. 10, 2014, that Hospira Inc. voluntarily recalled Bupivacaine HCl Inj. USP vials due to the presence of particulate matter. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Hospira
- Product: Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial
- NDC: 0409-1162-02
- Lot: 25-097-DK
- Expiration: 01/01/2015
The hazard
The recall addresses confirmed customer reports of visible particulate embedded in the glass vial. The FDA classified the issue as a Class II recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (July 24, 2026), Apollo Care SEMAGLUTIDE 5mg Vial Recall (July 29, 2026), and GE Healthcare Omnipaque 300 mg/mL Injection Recall (March 24, 2026).